General Motors Company (NYSE: GM) is reportedly affected by an issue with assembling battery modules of electric vehicles, poising headwinds to ramp up production.
Clearmind Medicine shares are up Tuesday after the company announced it signed an exclusive patent licensing agreement with Yissum Research Development.